LA JOLLA, CA--(Marketwire - February 14, 2008) - Transdel Pharmaceuticals, Inc. (OTCBB: TDLP), a specialty pharmaceutical company focused on the development and commercialization of non-invasive topically targeted medications, announced today that the presentation day, time and location for Dr. Juliet Singh, President and Chief Executive Officer, at the ROTH Capital Partners 20th Annual OC Growth Stock Conference has been changed to Wednesday, February 20th at 9:00 a.m. PST. The conference will be held at the Ritz Carlton Hotel in Laguna Niguel, California and the presentation in the Ritz Ballroom, Salon 3.
